We have publications on different health topics for you to access. Filter by topic, publication type, audience, condition and disease.
COVID-19 vaccination – When to get your COVID-19 vaccination (Aboriginal and Torres Strait Islander people)
This infographic explains when you can get your COVID-19 vaccination.Part of a collection: COVID-19 vaccination – Aboriginal and Torres Strait Islander vaccine provider resources, COVID-19 vaccination – Third and fourth doses for Aboriginal and Torres Strait Islander people, COVID-19 vaccination – General COVID-19 vaccine information for Aboriginal and Torres Strait Islander people
This newsletter provides key health updates for Aboriginal and Torres Strait Islander households, communities and stakeholders.
COVID-19 vaccination – Phase 2A of COVID-19 Vaccine Strategy – Privacy Impact Assessment report and Agency response
These documents contain a report of the Privacy Impact Assessment for the implementation of Phase 2A of the COVID-19 Vaccine Strategy and the Department of Health’s consolidated response.
Life Saving Drugs Program – Mucopolysaccharidosis type IVA (MPS IVA) – Patient test results spreadsheet
Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program.
Electronic National Residential Medication Chart (eNRMC) transitional arrangement – Pharmacy information pack
Residential aged care providers can start using transitional eNRMC products from 1 July 2022. This document provides information for pharmacies about these transitional eNRMC products and how to use them.
This fact sheet provides information about Ogivri®, Herzuma®, Kanjinti®, Ontruzant® and Trazimera®, which are biosimilar brands of trastuzumab listed on the Pharmaceutical Benefits Scheme (PBS).
This National Notifiable Diseases Surveillance System (NNDSS) dataset provides records of salmonella cases from 2009 to 2021, by month and other patient variables. We update it in July of each year to include the previous year's notifications and all updates.
National Notifiable Diseases Surveillance System (NNDSS) public dataset – meningococcal disease (invasive)
This National Notifiable Diseases Surveillance System (NNDSS) dataset provides records of invasive meningococcal disease cases from 2009 to 2021, by month and other patient variables. We update it in July of each year to include the previous year's notifications and all updates.
The Stoma Appliance Scheme schedule lists all of the stoma-related products and appliances that we subsidise under the scheme. You can view the full list, or just the additions, deletions or variations.
Treating physicians use this application form to apply for a patient to access LSDP medication for MPS IVA for the first time, or after a break.
Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS IVA.
These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type IVA (MPS IVA) under the Life Saving Drugs Program.